Fresenius Medical Care AG (FMS): Price and Financial Metrics


Fresenius Medical Care AG (FMS)

Today's Latest Price: $42.48 USD

0.61 (1.46%)

Updated Nov 27 5:00pm

Add FMS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

FMS Stock Summary

  • FMS has a higher market value than 91.54% of US stocks; more precisely, its current market capitalization is $25,346,052,825.
  • With a year-over-year growth in debt of 60.79%, Fresenius Medical Care AG & Co KGaA's debt growth rate surpasses 83.99% of about US stocks.
  • In terms of volatility of its share price, FMS is more volatile than merely 11.42% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Fresenius Medical Care AG & Co KGaA are MKC, NTR, AMCR, TSN, and K.
  • Visit FMS's SEC page to see the company's official filings. To visit the company's web site, go to www.freseniusmedicalcare.com.

FMS Stock Price Chart Interactive Chart >

Price chart for FMS

FMS Price/Volume Stats

Current price $42.48 52-week high $46.55
Prev. close $41.87 52-week low $29.17
Day low $41.90 Volume 71,798
Day high $42.48 Avg. volume 282,157
50-day MA $41.73 Dividend yield 1.18%
200-day MA $40.55 Market Cap 24.88B

Fresenius Medical Care AG (FMS) Company Bio


Fresenius Medical Care provides dialysis care services related to the dialysis treatment a patient receives with end stage renal disease, and other health care services. The company was founded in 1996 and is based in Bad Homburg, Germany.

FMS Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$42.48$85.65 102%

Below please find a table outlining a discounted cash flow forecast for FMS, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Fresenius Medical Care AG & Co KGaA ranked in the 63th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Fresenius Medical Care AG & Co KGaA, consider:

  • 48% of the company's capital comes from equity, which is greater than merely 22.1% of stocks in our cash flow based forecasting set.
  • Fresenius Medical Care AG & Co KGaA's weighted average cost of capital (WACC) is 6%; for context, that number is higher than merely 1.59% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), Fresenius Medical Care AG & Co KGaA has a reliance on debt greater than 89.12% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%98%
1%100%
2%102%
3%104%
4%106%
5%108%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as FMS, try DVA, FZMD, ANTM, CHE, and NVO.


FMS Latest News Stream


Event/Time News Detail
Loading, please wait...

FMS Latest Social Stream


Loading social stream, please wait...

View Full FMS Social Stream

Latest FMS News From Around the Web

Below are the latest news stories about Fresenius Medical Care AG & Co KGaA that investors may wish to consider to help them evaluate FMS as an investment opportunity.

Alucent Biomedical Announces $35 Million Series B Financing Led by a Multinational Strategic Investor

SALT LAKE CITY--(BUSINESS WIRE)-- #AlucentNVS--Alucent Biomedical closes $35 million Series B financing round led by a large multinational strategic investor and joined by Fresenius Medical.

Business Wire | October 1, 2020

Vascular Access Devices Market: Global Type Analysis By BD, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Cook, Baxter

Global Vascular Access Devices Market By Type (Central Vascular Access Devices, Peripheral Vascular Access Devices, Accessories), Mode of Insertion (Intravenous, Subcutaneous), Application (Drug Administration, Fluid & Nutrition Administration, Blood Transfusion, Diagnostics & Testing), End User (Hospitals, Clinics & Ambulatory Care Centers,

OpenPR | September 30, 2020

Peritoneal Dialysis Market - Global Outlook & Forecast Report 2020-2025 Featuring Baxter International, Fresenius Medical Care, Medionics, Medtronic

DUBLIN, Sept. 28, 2020 /PRNewswire/ -- The "Peritoneal Dialysis Market - Global Outlook & Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The peritoneal dialysis market by revenue is expected to grow at a CAGR of over 6% during the period 2019-2025 Market…

PR Newswire | September 28, 2020

European advisory group backs expanded use of Vifor Fresenius' Velphoro

The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Vifor Fresenius Medical Care Renal Pharma's Velphoro (mixture of polynuclear iron ((III))-oxyhydroxide, sucrose and starches) for the control of serum phosphorus levels in pediatric patients at least two years old with chronic kidney disease ((CKD))...

Seeking Alpha | September 18, 2020

Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day

HONG KONG--(BUSINESS WIRE)-- #chronickidneydisease--Fresenius Medical Care, the world’s leading provider of dialysis products and services, today announced the launch of the organization’s first World Patient Safety Day initiative to raise awareness of the importance of ultrapure dialysis fluid for developing economies across Asia Pacific. On 17 September each year, the World Health Organization (WHO), international partners and all countries commemorate World Patient Safety Day: a day that aims to increase global awa

Business Wire | September 16, 2020

Read More 'FMS' Stories Here

FMS Price Returns

1-mo 11.12%
3-mo 0.24%
6-mo -0.81%
1-year 17.33%
3-year -12.12%
5-year 7.04%
YTD 16.70%
2019 15.01%
2018 -37.85%
2017 25.49%
2016 1.62%
2015 13.81%

FMS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full FMS Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9668 seconds.